drugset / Trial / NCT01924143
TD-9855 Mass Balance Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the absorption, distribution, metabolism, and excretion (ADME) of a single oral dose of \[14C\]TD-9855
Timeline
- Start
- 2013-10
- Primary completion
- 2013-11
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ampreloxetine | Small molecule | 20 mg | Oral |